Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, ...

Researchers have discovered that prostate cancer depends on two key enzymes, PDIA1 and PDIA5, to survive and resist therapy. When blocked, these enzymes cause the androgen receptor to collapse, ...

Prostate-targeted, engineered nanoparticles made of amorphous silica are effective in killing prostate tumors directly while ...

Cancer cells are remarkably good at adapting to stress. When treatments damage them, they often find new ways to survive, fueling drug resistance and disease progression.

Prostate cancer (PCa) is a prevalent malignant tumor of the urinary system and remains the most common cancer among males. In this study, we showed that YTHDF1, one of the reader proteins involved in ...

This research sought to assess the expression pattern and biological function of tRF-3017b in prostate cancer, and to elucidate whether tRF-3017b promotes tumor progression by modulating tumor cell ...

THOUSANDS of men with prostate cancer are to get ultra high-powered radiotherapy on the NHS for the first time.  The ...

Prostate cancer is often called a “silent killer,” and for good reason. You don’t get a big set of warnings, and for a lot of ...

The US is in the middle of an estrogen patch shortage, with menopausal women struggling to get ahold of hormone therapy to ...

For 80 years Oak Ridge National Laboratory has produced isotopes that treat cancer and power deep space exploration.

Know the 8 prostate cancer symptoms to watch for, from urinary changes to bone pain, plus who is most at risk and when to get ...